Zobrazeno 1 - 10
of 37
pro vyhledávání: '"X, de Gracia"'
Autor:
G. Cárdenas, S. Redecillas, H. Segurola, X. De Gracia, A. Alvarez, N. Garcia, R. Lorite, B. Sarto, Rosa Burgos
Publikováno v:
Clinical Nutrition. 35:S83-S84
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::137b47d9b903f54badbad9b99f0c13c7
https://doi.org/10.1016/s0261-5614(16)30449-6
https://doi.org/10.1016/s0261-5614(16)30449-6
Autor:
T Lester, J. M. Bertran, M. Hernández, Hubert B. Gaspar, E. Ashton, Christine Kinnon, Teresa Espanol, X. De gracia, I. Caragol, M. Ferrando
Publikováno v:
Clinical and Experimental Immunology. 120:346-350
SUMMARY X-linked agammaglobulinaemia (XLA) is a B cell humoral abnormality arising from mutations in the gene encoding Bruton’s tyrosine kinase (Btk). The phenotype of XLA can be variable, with some individuals having a less severe immunophenotype,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b0d599448f395366023783483c27413
https://doi.org/10.1046/j.1365-2249.2000.01230.x
https://doi.org/10.1046/j.1365-2249.2000.01230.x
Publikováno v:
Archivos de Bronconeumología. 28:39-44
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb4fee446fd544fd454ba641c41c926a
https://doi.org/10.1016/s0300-2896(15)31387-9
https://doi.org/10.1016/s0300-2896(15)31387-9
Autor:
H. Segurola, J. Riera, X. De Gracia, G. Cárdenas, R. Lorite, V. Aviles, A. Alvarez, B. Sarto, S. Redecillas, Rosa Burgos, A. Roman, N. Garcia
Publikováno v:
Clinical Nutrition. 34:S42
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0f9d2b08c85d0f19cc11428e2490e5f
https://doi.org/10.1016/s0261-5614(15)30202-8
https://doi.org/10.1016/s0261-5614(15)30202-8
Autor:
I, Alfageme, J, Aspa, S, Bello, J, Blanquer, R, Blanquer, L, Borderías, C, Bravo, R, de Celis, X, de Gracia, J, Dorca, J, Gallardo, M, Gallego, R, Menéndez, L, Molinos, C, Paredes, O, Rajas, J, Rello, F, Rodríguez de Castro, J, Roig, F, Sánchez-Gascón, A, Torres, R, Zalacaín
Publikováno v:
Archivos de bronconeumologia. 41(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce42e2529243a776a791edde9f6263f0
https://pubmed.ncbi.nlm.nih.gov/15919009
https://pubmed.ncbi.nlm.nih.gov/15919009
Autor:
A. Alvarez, J.A. Lopez, G. Cárdenas, C. Perez-Portabella, H. Segurola, R. Burgos, X. De Gracia
Publikováno v:
Clinical Nutrition Supplements. 7:88-89
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08229a8f5880bf186181987d868a9d5f
https://doi.org/10.1016/s1744-1161(12)70209-0
https://doi.org/10.1016/s1744-1161(12)70209-0
Autor:
B. Sarto, H. Segurola, N. Garcia, Rosa Burgos, S. Redecillas, X. De Gracia, G. Cárdenas, A. Alvarez
Publikováno v:
Clinical Nutrition. 33:S175
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38203c044b83c2f741c986018907af76
https://doi.org/10.1016/s0261-5614(14)50458-x
https://doi.org/10.1016/s0261-5614(14)50458-x
Autor:
X de Gracia, María Antolín, Francesc Casellas, Eva C. Vaquero, Juan-Ramon Malagelada, Luisa Guarner
Publikováno v:
Scopus-Elsevier
The present study was designed to investigate the prevalence of bacterial overgrowth in patients with exocrine pancreatic insufficiency by using the hydrogen breath test with glucose. Thus, in 30 patients with exocrine pancreatic insufficiency (in 15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f8daef731c15350f186d594b1240748
https://pubmed.ncbi.nlm.nih.gov/9598808
https://pubmed.ncbi.nlm.nih.gov/9598808
Autor:
H. Segurola Gurrutxaga, G. Cárdenas Lagranja, A. Alvarez, G. Simats Oriol, N. Garcia Barrasa, C. Perez-Portabella, X. De Gracia, R. Burgos Peláez
Publikováno v:
Clinical Nutrition. 32:S171
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7f256e4285a3e2ba0583d083270ccb6
https://doi.org/10.1016/s0261-5614(13)60443-4
https://doi.org/10.1016/s0261-5614(13)60443-4
Publikováno v:
Medicina clinica. 97(13)
The hepatic toxicity of antituberculous drugs used for the therapy of initial cases was evaluated, assessing the incidence and severity and its relation with each drug, age, other associated hepatic risks and the chronological time of therapy.1235 pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f74626232883ca4261a72c5576e6e275
https://pubmed.ncbi.nlm.nih.gov/1758204
https://pubmed.ncbi.nlm.nih.gov/1758204